Literature DB >> 2906157

Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil.

H Bastuji1, M Jouvet.   

Abstract

1. Modafinil, a putative central alpha 1 adrenergic agonist, was tested in idiopathic hypersomnia and narcolepsy. 2. Sleep attacks and drowsiness were significantly decreased in 83% of 18 hypersomniac subjects and 71% of 24 narcoleptics. 3. When cataplectic episodes were not totally suppressed the association of a low dose of Clomipramine was successful in improving them. 4. Modafinil, used for at least 3 years in some patients, produces, in most cases, no peripheric sides effects, does not disturb night sleep and is never responsible of tolerance of drug dependence.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2906157     DOI: 10.1016/0278-5846(88)90014-0

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  47 in total

Review 1.  Idiopathic Hypersomnia.

Authors:  Lynn Marie Trotti
Journal:  Sleep Med Clin       Date:  2017-06-16

Review 2.  Narcolepsy in children: a practical guide to its diagnosis, treatment and follow-up.

Authors:  C Guilleminault; R Pelayo
Journal:  Paediatr Drugs       Date:  2000 Jan-Feb       Impact factor: 3.022

3.  Changes in EEG spectral power in the prefrontal cortex of conscious rats elicited by drugs interacting with dopaminergic and noradrenergic transmission.

Authors:  C Sebban; X Q Zhang; B Tesolin-Decros; M J Millan; M Spedding
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

4.  Stress modulation of the memory retrograde-enhancing effects of the awakening drug modafinil in mice.

Authors:  Daniel Béracochéa; Pierrette Liscia; Christophe Tronche; Frédéric Chauveau; Jean-Claude Jouanin; Christophe Piérard
Journal:  Psychopharmacology (Berl)       Date:  2007-10-13       Impact factor: 4.530

5.  Suppression of hippocampal cell proliferation by short-term stimulant drug administration in adult rats.

Authors:  Linda J Kochman; Casimir A Fornal; Barry L Jacobs
Journal:  Eur J Neurosci       Date:  2009-06-01       Impact factor: 3.386

Review 6.  The neuropsychopharmacology of action inhibition: cross-species translation of the stop-signal and go/no-go tasks.

Authors:  Dawn M Eagle; Andrea Bari; Trevor W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2008-06-10       Impact factor: 4.530

7.  Clinical screening for narcolepsy/cataplexy in patients with fibromyalgia.

Authors:  P Disdier; P Genton; G Bolla; D Verrot; C Christides; J R Harlé; P J Weiller
Journal:  Clin Rheumatol       Date:  1994-03       Impact factor: 2.980

8.  Modafinil : A Review of its Pharmacology and Clinical Efficacy in the Management of Narcolepsy.

Authors:  K J McClellan; C M Spencer
Journal:  CNS Drugs       Date:  1998-04       Impact factor: 5.749

Review 9.  Clinical pharmacokinetic profile of modafinil.

Authors:  Philmore Robertson; Edward T Hellriegel
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

10.  The vigilance-promoting drug modafinil counteracts the reduction of tyrosine hydroxylase immunoreactivity and of dopamine stores in nigrostriatal dopamine neurons in the male rat after a partial transection of the dopamine pathway.

Authors:  A Ueki; L Rosén; B Andbjer; U B Finnman; U Altamimi; A M Janson; M Goldstein; L F Agnati; K Fuxe
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.